Page last updated: 2024-09-03

dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii and Plasma Cell Tumor

dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii has been researched along with Plasma Cell Tumor in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, M; Engel, J; Jennerwein, M; Schönenberger, H; von Angerer, E; Wappes, B; Wrobel, KH1

Other Studies

1 other study(ies) available for dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii and Plasma Cell Tumor

ArticleYear
Dichloro[1,2-bis(4-hydroxyphenyl)ethylenediamine]platinum(II) complexes: an approach to develop compounds with a specific effect on the hormone-dependent mammary carcinoma.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:10

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line; Drug Evaluation, Preclinical; Estradiol; Female; Humans; Indicators and Reagents; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Molecular Conformation; Organoplatinum Compounds; Plasmacytoma; Rats; Rats, Inbred Strains; Receptors, Estradiol; Structure-Activity Relationship

1984